{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:09:24Z","timestamp":1795201764490,"version":"4.10.3"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mam.2025.101421","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:45:24Z","timestamp":1762785924000},"page":"101421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Navigating the ocular barrier: Viral- and nanotechnology-based delivery systems as promising therapeutic agents for ocular diseases"],"prefix":"10.1016","volume":"106","author":[{"given":"Subo","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mam.2025.101421_bib1","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s13346-022-01196-5","article-title":"Light-responsive biomaterials for ocular drug delivery","volume":"13","author":"Abdelmohsen","year":"2023","journal-title":"Drug Deliv.Trans. Res."},{"key":"10.1016\/j.mam.2025.101421_bib2","series-title":"Ocular Delivery of Viral Vectors for Retinal and Choroidal Vascular Diseases: a Review","author":"Agrawal","year":"2025"},{"issue":"31","key":"10.1016\/j.mam.2025.101421_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg8163","article-title":"Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies","volume":"9","author":"Ail","year":"2023","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.mam.2025.101421_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/gels8020082","article-title":"Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic system","volume":"8","author":"Akhter","year":"2022","journal-title":"Gels"},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/pharmaceutics17070927","article-title":"From structure to function: the promise of PAMAM dendrimers in biomedical applications","volume":"17","author":"Alamos-Musre","year":"2025","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.mam.2025.101421_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"Journal of pharmacy and pharmacology"},{"issue":"2","key":"10.1016\/j.mam.2025.101421_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1566523221666210423084233","article-title":"Gene therapy in the anterior eye segment","volume":"22","author":"Amador","year":"2022","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.mam.2025.101421_bib8","series-title":"Seminars in Ophthalmology","article-title":"Ocular surface disease and anti-glaucoma medications: various features, diagnosis, and management guidelines","year":"2023"},{"key":"10.1016\/j.mam.2025.101421_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178497","article-title":"Lentiviral vectors: from wild-type viruses to efficient multi-functional delivery vectors","author":"Arrasate","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.mam.2025.101421_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/pharmaceutics14081605","article-title":"Lentiviral vectors for ocular gene therapy","volume":"14","author":"Arsenijevic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mam.2025.101421_bib11","series-title":"Plastic and Thoracic Surgery, Orthopedics and Ophthalmology","first-page":"91","article-title":"Corneal epithelial wound healing and management strategies","author":"Asena","year":"2018"},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/v14050888","article-title":"Cytokine responses to adenovirus and adenovirus vectors","volume":"14","author":"Atasheva","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.mam.2025.101421_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.809118","article-title":"Gene therapy advances: a meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.mam.2025.101421_bib14","series-title":"Targeted Drug Delivery to Tumors: Myths, Reality and Possibility","first-page":"198","author":"Bae","year":"2011"},{"issue":"10","key":"10.1016\/j.mam.2025.101421_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/nano14100846","article-title":"Production of PEGylated vancomycin-loaded niosomes by a continuous supercritical CO2 assisted process","volume":"14","author":"Baldino","year":"2024","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15171\/bi.2016.07","article-title":"Advanced drug delivery and targeting technologies for the ocular diseases","volume":"6","author":"Barar","year":"2016","journal-title":"Bioimpacts: BI"},{"key":"10.1016\/j.mam.2025.101421_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111775","article-title":"Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells","volume":"204","author":"Basu","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"9","key":"10.1016\/j.mam.2025.101421_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1089\/hum.2012.008","article-title":"Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat\u00ae, for age-related macular degeneration","volume":"23","author":"Binley","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib19","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.chemmater.6b00877","article-title":"Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity","volume":"28","author":"Bouchoucha","year":"2016","journal-title":"Chem. Mater."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2007.06.010","article-title":"Polymers and nanoparticles: intelligent tools for intracellular targeting?","volume":"68","author":"Breunig","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib21","first-page":"3978","article-title":"An HSV-1-Based vector platform for localized delivery to the posterior of the eye","volume":"65","author":"Cartwright","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.mam.2025.101421_bib22","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.3390\/ijms22094534","article-title":"An update on gene therapy for inherited retinal dystrophy: experience in leber congenital amaurosis clinical trials","volume":"22","author":"Chiu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib23","series-title":"Ocular Transporters and Receptors","first-page":"1","article-title":"Eye: anatomy, physiology and barriers to drug delivery","author":"Cholkar","year":"2013"},{"issue":"2","key":"10.1016\/j.mam.2025.101421_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2012.0200","article-title":"Novel strategies for anterior segment ocular drug delivery","volume":"29","author":"Cholkar","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.5114\/aoms.2016.61918","article-title":"Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions","volume":"12","author":"Das","year":"2016","journal-title":"Arch. Med. Sci."},{"issue":"11","key":"10.1016\/j.mam.2025.101421_bib27","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1099\/vir.0.19497-0","article-title":"Genetic content and evolution of adenoviruses","volume":"84","author":"Davison","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mam.2025.101421_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nwnano.2025.100094","article-title":"Engineering PAMAM dendrimers for optimized drug delivery","author":"Dehkordi","year":"2025","journal-title":"Nano Trends"},{"key":"10.1016\/j.mam.2025.101421_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape","author":"Desai","year":"2025","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/v13071288","article-title":"Lentiviral vectors for delivery of gene-editing systems based on CRISPR\/Cas: current state and perspectives","volume":"13","author":"Dong","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/polym17070833","article-title":"Polymeric nanoparticles in targeted drug delivery: unveiling the impact of polymer characterization and fabrication","volume":"17","author":"Eltaib","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.mam.2025.101421_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2025.100083","article-title":"Nanoparticles for drug delivery: insight into in vitro and in vivo drug release from nanomedicines","author":"Ewii","year":"2025","journal-title":"Nano Trans. Med."},{"issue":"2","key":"10.1016\/j.mam.2025.101421_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.723","article-title":"Biological drug therapy for ocular angiogenesis: anti-vegf agents and novel strategies based on nanotechnology","volume":"9","author":"Formica","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajo.2009.04.029","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes","volume":"148","author":"Fujiwara","year":"2009","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.copbio.2004.11.003","article-title":"In vivo molecular and cellular imaging with quantum dots","volume":"16","author":"Gao","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.mam.2025.101421_bib36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/ICL.0000000000000226","article-title":"Adenovirus ocular infections: prevalence, pathology, pitfalls, and practical pointers","volume":"44","author":"Garcia-Zalisnak","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.mam.2025.101421_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cis.2015.08.002","article-title":"Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses","volume":"233","author":"Gause","year":"2016","journal-title":"Adv. Colloid Interface Sci."},{"issue":"10","key":"10.1016\/j.mam.2025.101421_bib38","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1021\/acs.molpharmaceut.1c00650","article-title":"Ophthalmic nanoemulsions: from composition to technological processes and quality control","volume":"18","author":"Gawin-Miko\u0142ajewicz","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mam.2025.101421_bib39","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/OPTH.S364200","article-title":"Ocular gene therapy: a literature review with special focus on immune and inflammatory responses","author":"Ghoraba","year":"2022","journal-title":"Clin. Ophthalmol."},{"issue":"9","key":"10.1016\/j.mam.2025.101421_bib40","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/pharmaceutics16091158","article-title":"Lipid-based nanocarriers: bridging diagnosis and cancer therapy","volume":"16","author":"Giordano","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mam.2025.101421_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.mi.49.100195.003331","article-title":"Development and application of herpes simplex virus vectors for human gene therapy","volume":"49","author":"Glorioso","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"issue":"46","key":"10.1016\/j.mam.2025.101421_bib42","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.mam.2025.101421_bib44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jconrel.2023.08.004","article-title":"Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment","volume":"361","author":"Guo","year":"2023","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/biomedicines10010107","article-title":"Non-integrating lentiviral vectors in clinical applications: a glance through","volume":"10","author":"Gurumoorthy","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.mam.2025.101421_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.exer.2010.06.021","article-title":"The molecular basis of corneal transparency","volume":"91","author":"Hassell","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"9","key":"10.1016\/j.mam.2025.101421_bib48","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2013.176","article-title":"Covert warfare against the immune system: decoy capsids, stealth genomes, and suppressors","volume":"21","author":"Hoffman","year":"2013","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.mam.2025.101421_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.mam.2025.101421_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib51","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/biom15070940","article-title":"Adeno-associated virus vectors in retinal gene therapy: challenges, innovations, and future directions","volume":"15","author":"Huang","year":"2025","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1517\/14712598.2016.1131265","article-title":"Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy","volume":"16","author":"Hussain","year":"2016","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12575-021-00150-y","article-title":"A rat model for retinitis pigmentosa with rapid retinal degeneration enables drug evaluation in vivo","volume":"23","author":"Inoue","year":"2021","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.mam.2025.101421_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.rsurfi.2025.100529","article-title":"Advances in nanoparticles in targeted drug Delivery-A review","author":"Islam","year":"2025","journal-title":"Results Surf. Interfaces"},{"key":"10.1016\/j.mam.2025.101421_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib56","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/17425247.2022.2093854","article-title":"Protein corona: challenges and opportunities for targeted delivery of nanomedicines","volume":"19","author":"Jiang","year":"2022","journal-title":"Expet Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics16010131","article-title":"Chemistry and art of developing lipid nanoparticles for biologics delivery: focus on development and scale-up","volume":"16","author":"John","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mam.2025.101421_bib58","series-title":"Complex Ophthalmic Dosage Forms: Advances in Biomedical Applications and Future Perspectives","first-page":"307","article-title":"Safety and toxicities of nanocarriers in ophthalmic drug delivery system","author":"Kadiri","year":"2025"},{"issue":"2","key":"10.1016\/j.mam.2025.101421_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/biomedicines13020365","article-title":"Looking to the future of viral vectors in ocular gene therapy: clinical review","volume":"13","author":"Kharisova","year":"2025","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.mam.2025.101421_bib60","doi-asserted-by":"crossref","first-page":"ORSF5","DOI":"10.1167\/iovs.13-12789","article-title":"The prevalence of age-related eye diseases and visual impairment in aging: current estimates","volume":"54","author":"Klein","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2016.0273","article-title":"Ocular drug delivery and pharmacokinetics: influence of drug properties and delivery systems","volume":"94","author":"Kompella","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mam.2025.101421_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jtos.2023.05.007","article-title":"Corneal gene therapy: structural and mechanistic understanding","volume":"29","author":"Kumar","year":"2023","journal-title":"Ocul. Surf."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40662-022-00298-y","article-title":"Nanoparticles for the treatment of glaucoma-associated neuroinflammation","volume":"9","author":"Lambuk","year":"2022","journal-title":"Eye Vision"},{"issue":"9","key":"10.1016\/j.mam.2025.101421_bib64","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/gels9090718","article-title":"Advancements in nanogels for enhanced ocular drug delivery: cutting-edge strategies to overcome eye barriers","volume":"9","author":"Lee","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.mam.2025.101421_bib65","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.2147\/IJN.S532074","article-title":"Nanomedicine-based ophthalmic drug delivery systems for the treatment of ocular diseases","author":"Lin","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"20","key":"10.1016\/j.mam.2025.101421_bib66","doi-asserted-by":"crossref","first-page":"15352","DOI":"10.3390\/ijms242015352","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.mam.2025.101421_bib67","doi-asserted-by":"crossref","first-page":"16661","DOI":"10.3390\/ijms242316661","article-title":"Animal models in eye research: focus on corneal pathologies","volume":"24","author":"Loiseau","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib68","first-page":"215","article-title":"Therapeutic applications of viral vectors","author":"Lowenstein","year":"2023","journal-title":"Gene. Eng. Viruses: Garland Science"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13036-024-00414-7","article-title":"Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review","volume":"18","author":"Lv","year":"2024","journal-title":"J. Biol. Eng."},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib70","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2165\/00003088-200241120-00001","article-title":"Virus-based gene delivery systems","volume":"41","author":"Mah","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.mam.2025.101421_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101354","article-title":"The economics of vision impairment and its leading causes: a systematic review","volume":"46","author":"Marques","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib72","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of adeno-associated virus (AAV) and recombinant AAV vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.mam.2025.101421_bib73","series-title":"Adenovirus Gene Delivery for the Treatment of Ocular Diseases","year":"2003"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib74","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1038\/s41467-018-06621-3","article-title":"Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration","volume":"9","author":"Meliani","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2025.101421_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100862","article-title":"Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections","volume":"80","author":"Melo","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"194","key":"10.1016\/j.mam.2025.101421_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005795","article-title":"Overcoming preexisting humoral immunity to AAV using capsid decoys","volume":"5","author":"Mingozzi","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib77","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther. Deliv."},{"issue":"15","key":"10.1016\/j.mam.2025.101421_bib78","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2025.101421_bib79","article-title":"A review of novel nanoformulations for dry eye disease and treat ocular surface inflammation","author":"Nouralishahi","year":"2025","journal-title":"Nanomedicine Journal"},{"key":"10.1016\/j.mam.2025.101421_bib80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib81","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/v12121427","article-title":"Toward tightly tuned gene expression following lentiviral vector transduction","volume":"12","author":"Page","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.mam.2025.101421_bib82","first-page":"687","article-title":"Applications and developments of gene therapy drug delivery systems for genetic diseases","volume":"16","author":"Pan","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib83","doi-asserted-by":"crossref","DOI":"10.2174\/0115665232367377250519114910","article-title":"Next-generation nucleic acid delivery: a review of nanobiosystemc design and applications","author":"Parashar","year":"2025","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.mam.2025.101421_bib84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-08-102680-9.00013-5","article-title":"Inorganic nanoparticles for targeted drug delivery","author":"Paul","year":"2020","journal-title":"Biointegrat. Med. Implant Mater."},{"key":"10.1016\/j.mam.2025.101421_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126192","article-title":"Smart inorganic nanoparticles in nanomedicine: strategies for synthesis and functionalization","author":"Percoco","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.mam.2025.101421_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40005-019-00442-2","article-title":"PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid)(PLGA) copolymers for the design of drug delivery systems","volume":"49","author":"Perinelli","year":"2019","journal-title":"J. Pharm. Invest."},{"issue":"4","key":"10.1016\/j.mam.2025.101421_bib87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/17425247.2014.882315","article-title":"Contact lenses for antifungal ocular drug delivery: a review","volume":"11","author":"Phan","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.mam.2025.101421_bib88","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.omtm.2019.08.015","article-title":"Clinical considerations for capsid choice in the development of liver-targeted AAV-based gene transfer","volume":"15","author":"Pipe","year":"2019","journal-title":"Mol. Therapy Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.mam.2025.101421_bib89","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity","volume":"46","author":"Pitkanen","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib90","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ICU.0000000000000660","article-title":"Gene therapy beyond luxturna: a new horizon of the treatment for inherited retinal disease","volume":"31","author":"Prado","year":"2020","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib91","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1515\/biol-2018-0035","article-title":"Nanoparticles as carriers of proteins, peptides and other therapeutic molecules","volume":"13","author":"Pudlarz","year":"2018","journal-title":"Open Life Sci."},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib92","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: the Rubik's cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.mam.2025.101421_bib93","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1167\/iovs.11-9139","article-title":"Nanoparticle-mediated delivery of shRNA. VEGF-a plasmids regresses corneal neovascularization","volume":"53","author":"Qazi","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib94","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.stemcr.2019.03.002","article-title":"Human iPSC-derived retinas recapitulate the fetal CRB1 CRB2 complex formation and demonstrate that photoreceptors and m\u00fcller glia are targets of AAV5","volume":"12","author":"Quinn","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.mam.2025.101421_bib95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib96","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-981-97-3115-2_8","article-title":"Progress and prospect of nanocarriers: design, concept, and recent advances","author":"Rauf","year":"2024","journal-title":"Nanotheranost. Diagnosis Ther."},{"issue":"7","key":"10.1016\/j.mam.2025.101421_bib97","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1021\/acs.molpharmaceut.8b00331","article-title":"Effective remodelling of human osteoarthritic cartilage by sox9 gene transfer and overexpression upon delivery of rAAV vectors in polymeric micelles","volume":"15","author":"Rey-Rico","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib98","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12967-024-05160-4","article-title":"Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field","volume":"22","author":"Riccardi","year":"2024","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.mam.2025.101421_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1449","article-title":"Gold nanoparticle\u2010mediated photothermal therapy: applications and opportunities for multimodal cancer treatment","volume":"9","author":"Riley","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.mam.2025.101421_bib100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/ecp.12.55","article-title":"Pharmacologic and clinical profile of dexamethasone intravitreal implant","volume":"5","author":"Robinson","year":"2012","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2025.101421_bib101","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s13346-016-0330-y","article-title":"Human corneal cell culture models for drug toxicity studies","volume":"6","author":"R\u00f6nkk\u00f6","year":"2016","journal-title":"Drug Deliv.Trans. Res."},{"issue":"18","key":"10.1016\/j.mam.2025.101421_bib102","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.3390\/molecules26185577","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"26","author":"Rykowska","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.mam.2025.101421_bib103","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.65.11.28","article-title":"Mathematical models of ocular drug delivery","volume":"65","author":"Sadeghi","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126009","article-title":"Revolutionizing age-related macular degeneration treatment: advances and future directions in non-invasive retinal drug delivery systems","author":"Sahu","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib105","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","article-title":"Risks associated with lentiviral vector exposures and prevention strategies","volume":"58","author":"Schlimgen","year":"2016","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.mam.2025.101421_bib106","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.pmbts.2024.08.003","article-title":"Delivery of therapeutic proteins to ocular tissues: barriers, approaches, regulatory considerations and future perspectives","volume":"212","author":"Shastri","year":"2025","journal-title":"Progress Mol. Biol. Trans. Sci."},{"key":"10.1016\/j.mam.2025.101421_bib107","series-title":"Drug Delivery Aspects","first-page":"57","article-title":"Large-scale manufacturing of nanoparticles\u2014An industrial outlook","author":"Shegokar","year":"2020"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib108","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12951-025-03442-7","article-title":"Nano-formulations in disease therapy: designs, advances, challenges, and future directions","volume":"23","author":"Shi","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib109","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2144\/02331dd04","article-title":"Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid","volume":"33","author":"Smith","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.mam.2025.101421_bib111","series-title":"Nano-Biomaterials for Ophthalmic Drug Delivery","first-page":"483","article-title":"Ocular drug delivery: impact of in vitro cell culture models","author":"Solanki","year":"2016"},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/ph18030293","article-title":"Preclinical retinal disease models: applications in drug development and translational research","volume":"18","author":"Soundara Pandi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mam.2025.101421_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108196","article-title":"Adeno-associated virus mediated gene therapy for neuroprotection of retinal ganglion cells in glaucoma","volume":"206","author":"Starr","year":"2023","journal-title":"Vis. Res."},{"issue":"13","key":"10.1016\/j.mam.2025.101421_bib114","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.3390\/ijms25137333","article-title":"Viral and non-viral systems to deliver gene therapeutics to clinical targets","volume":"25","author":"Taghdiri","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/APO.0000000000000290","article-title":"Retinal dystrophies and the road to treatment: clinical requirements and considerations","volume":"9","author":"Talib","year":"2020","journal-title":"Asia-Pacific J. Ophthalmol."},{"key":"10.1016\/j.mam.2025.101421_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101234","article-title":"Squishy matters\u2013Corneal mechanobiology in health and disease","volume":"99","author":"Thomasy","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"issue":"88","key":"10.1016\/j.mam.2025.101421_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"22","key":"10.1016\/j.mam.2025.101421_bib118","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.3390\/ijms222212368","article-title":"Nanotechnology for topical drug delivery to the anterior segment of the eye","volume":"22","author":"Vaneev","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mam.2025.101421_bib119","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/mthe.2000.0213","article-title":"A tumultuous year for gene therapy","volume":"2","author":"Verma","year":"2000","journal-title":"Mol. Ther."},{"issue":"21","key":"10.1016\/j.mam.2025.101421_bib121","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib122","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/1521-2254(200009\/10)2:5<308::AID-JGM131>3.0.CO;2-3","article-title":"Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy","volume":"2","author":"Vigna","year":"2000","journal-title":"J. Gene Med."},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib123","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3390\/ijms26052213","article-title":"Progress in AAV-mediated in vivo gene therapy and its applications in central nervous system diseases","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.mam.2025.101421_bib124","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/v13122502","article-title":"Adenovirus biology, recombinant adenovirus, and adenovirus usage in gene therapy","volume":"13","author":"Watanabe","year":"2021","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.mam.2025.101421_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107939","article-title":"Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration","volume":"26","author":"Wei-Zhang","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib126","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mam.2025.101421_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1310050","article-title":"Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies","volume":"10","author":"Xia","year":"2023","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.mam.2025.101421_bib128","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5487973","article-title":"Sustained and efficient delivery of antivascular endothelial growth factor by the adeno\u2010associated virus for the treatment of corneal neovascularization: an outlook for its clinical translation","volume":"2024","author":"Xie","year":"2024","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.mam.2025.101421_bib129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2018.05.020","article-title":"A comprehensive review on contact lens for ophthalmic drug delivery","volume":"281","author":"Xu","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mam.2025.101421_bib130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.reth.2024.06.019","article-title":"Novel fabrication of anti-VEGF drug ranibizumab loaded PLGA\/PLA co-polymeric nanomicelles for long-acting intraocular delivery in the treatment of age-related macular degeneration therapy","volume":"26","author":"Xu","year":"2024","journal-title":"Regenerat. Ther."},{"issue":"5","key":"10.1016\/j.mam.2025.101421_bib131","article-title":"Contact lens as an emerging platform for ophthalmic drug delivery: a systematic review","volume":"18","author":"Yang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.mam.2025.101421_bib132","first-page":"4093","article-title":"Corneal epithelial tight junctions and their response to lipopolysaccharide challenge","volume":"41","author":"Yi","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"22","key":"10.1016\/j.mam.2025.101421_bib133","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/cells13221916","article-title":"Clinical and translational landscape of viral gene therapies","volume":"13","author":"Yudaeva","year":"2024","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.mam.2025.101421_bib134","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/jacs.0c01853","article-title":"An analysis of the binding function and structural organization of the protein corona","volume":"142","author":"Zhang","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mam.2025.101421_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.preme.2025.100037","article-title":"Surface engineering of nanoparticles for precision medicine","author":"Zheng","year":"2025","journal-title":"Precision Med. Eng."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T19:22:43Z","timestamp":1765308163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":135,"alternative-id":["S0098299725000858"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101421","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the ocular barrier: Viral- and nanotechnology-based delivery systems as promising therapeutic agents for ocular diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101421"}}